Pieris pharmaceuticals, inc. (PIRS)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Jun'13
Assets
Current assets:
Cash and cash equivalents

47,431

62,260

46,068

54,901

52,094

74,867

89,482

50,576

109,521

37,878

-

-

-

29,356

-

-

-

-

32,254

10,027

13,167

18,474

0

11

0

3,689

5

Short term investments

39,333

41,894

40,175

44,782

58,685

53,240

47,822

100,399

50,061

34,751

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash

-

-

-

-

-

-

-

-

-

-

89,921

50,325

55,241

-

36,557

40,374

31,188

29,349

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

72

-

Accounts receivable

7,267

6,787

6,952

7,174

7,128

2,701

5,338

2,559

3,309

15,546

2,537

48,470

39

57

-

-

70

-

17

-

-

-

-

-

-

481

-

Prepaid expenses and other current assets

4,341

4,072

4,778

4,605

6,379

4,574

4,207

3,065

3,190

1,615

2,817

3,947

3,475

3,260

4,579

3,505

3,608

2,311

-

-

-

1,331

-

-

-

-

-

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,285

1,866

1,275

-

-

-

-

449

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

589

732

507

-

-

0

-

60

0

Income tax receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

16

15

-

-

-

-

66

-

Total current assets

98,372

115,013

97,973

111,462

124,286

135,382

146,849

156,599

166,081

89,790

95,276

102,743

58,755

32,673

41,137

43,880

34,866

31,660

34,150

12,641

14,965

19,805

-

-

-

4,820

-

Property and equipment, net

20,344

19,502

11,008

7,888

4,893

5,049

4,687

4,597

4,445

4,034

3,455

3,085

2,993

2,264

2,447

2,446

2,210

2,162

1,928

1,811

1,785

2,052

-

-

-

2,437

-

Operating lease right-of-use assets

3,170

3,436

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long term investments

-

-

-

-

-

-

0

700

2,583

9,922

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

24

23

-

-

-

-

18

-

Other non-current assets

1,887

3,146

7,770

11,490

1,869

910

121

129

130

130

129

128

126

126

127

127

128

126

97

-

-

-

-

-

-

-

-

Total assets

123,773

141,097

116,751

130,840

131,048

141,341

151,657

162,025

173,239

103,876

98,861

105,956

61,875

35,063

43,712

46,454

37,205

33,950

36,200

14,477

16,774

21,857

0

11

0

7,276

5

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

3,500

5,803

5,436

4,031

3,728

3,350

2,693

3,174

1,934

2,452

2,601

4,646

3,317

2,386

-

-

-

1,058

-

-

-

-

0

0

-

-

-

Accrued expenses and other current liabilities

6,939

9,944

7,170

8,491

9,216

9,114

5,981

4,562

6,578

6,170

-

-

-

3,719

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues, current portion

10,044

11,256

27,242

28,406

28,181

35,612

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trade accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,523

1,638

1,711

-

1,117

2,058

1,539

1,260

-

-

-

278

-

Accrued expenses and other current liabilities

-

-

-

-

-

-

-

-

-

-

5,099

6,350

2,958

-

2,898

2,325

2,322

1,739

-

-

-

986

-

-

-

-

-

Deferred Revenue, Current

-

-

-

-

-

-

31,920

44,598

46,251

37,153

31,336

24,798

5,168

2,275

2,529

2,455

2,464

-

-

-

-

-

-

-

-

544

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,033

635

413

-

0

0

2

559

0

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

24

23

-

-

-

-

18

-

Other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

65

304

274

-

-

-

-

160

-

Bank loan, including accrued interest, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,270

-

-

-

206

-

Total current liabilities

20,483

27,003

39,848

40,928

41,125

48,076

40,594

52,334

54,763

45,775

39,037

35,795

11,444

8,380

9,951

6,419

6,497

2,797

2,241

3,022

2,250

3,517

-

-

-

1,768

-

Deferred revenue, net of current portion

38,560

47,258

44,179

58,110

59,734

53,303

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

14,924

15,484

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred Revenue, Noncurrent

-

-

-

-

-

-

60,770

54,336

67,746

46,542

55,221

60,784

32,352

1,409

2,233

2,701

3,491

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

-

-

12,082

12,317

27

27

32

37

37

37

43

42

42

47

44

42

39

23

-

307

-

-

-

-

-

-

-

Accrued expenses and other non-current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

333

-

-

-

-

-

Accrued expenses, non-current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

308

-

296

-

-

-

-

379

-

Convertible stockholder loan, including accrued interest, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,098

-

Bank loan, including accrued interest, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,445

-

Due to Related Parties, Noncurrent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2

-

0

Total liabilities

73,967

89,745

96,109

111,355

100,886

101,406

101,396

106,707

122,546

92,354

94,302

96,622

43,839

9,836

12,230

9,163

10,029

2,821

2,549

3,330

2,547

3,851

1

1

4

6,691

0

Stockholders’ equity:
Preferred stock

0

0

-

-

-

-

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

0

-

Common stock

55

55

49

49

49

54

54

54

54

45

44

43

43

43

43

43

39

39

39

29

29

29

6

6

5

11

5

Additional paid-in capital

228,751

227,468

194,695

192,956

191,224

189,929

188,644

187,067

185,638

136,484

134,803

132,125

130,101

129,350

128,870

128,484

112,595

112,226

-

-

-

-

-

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

111,725

85,503

85,155

84,627

-

-

-

57,608

-

Receivable from issuance of shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

121

-

Accumulated other comprehensive loss

-1,227

-1,995

-697

-2,707

-2,056

-2,982

-3,053

-2,574

-5,973

-4,695

-2,487

-2,092

-1,450

-1,501

-1,325

-1,325

-1,432

-1,272

-1,150

-1,343

-1,445

-843

-

-

-

-956

-

Additional Paid in Capital, Preferred Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

19

0

-

0

Accumulated deficit

-177,773

-174,176

-173,405

-170,813

-159,055

-147,066

-135,384

-129,229

-129,026

-120,312

-127,802

-120,743

-110,658

-102,665

-96,106

-89,910

-84,026

-79,865

-76,964

-73,041

-69,511

-65,807

-29

-15

-9

-55,957

-0

Total stockholders’ equity

49,806

51,352

20,642

19,485

30,162

39,935

50,261

55,318

50,693

11,522

4,558

9,333

18,035

25,227

31,482

37,291

27,176

31,128

33,650

11,147

14,227

18,006

-

-

-

585

-

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

10

-4

-

4

Common Stock, Shares Authorized

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

75,000

75,000

75,000

-

75,000

Common Stock, Shares Issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,250

6,100

5,000

-

5,000

Common Stock, Shares Outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,250

6,100

5,000

-

5,000

Total liabilities and stockholders’ equity

123,773

141,097

116,751

130,840

131,048

141,341

151,657

162,025

173,239

103,876

98,861

105,956

61,875

35,063

43,712

46,454

37,205

33,950

36,200

14,477

16,774

21,857

0

11

0

7,276

5

Series A Convertible Preferred Stock
Preferred stock, $0.001 par value per share, 10,000,000 shares authorized at December 31, 2019 and 2018, respectively

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B Convertible Preferred Stock
Preferred stock, $0.001 par value per share, 10,000,000 shares authorized at December 31, 2019 and 2018, respectively

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series C Convertible Preferred Stock
Preferred stock, $0.001 par value per share, 10,000,000 shares authorized at December 31, 2019 and 2018, respectively

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-